Literature DB >> 2202218

Karyotype/phenotype controversy: genetic and molecular implications of alternative hypotheses.

G N Wilson1.   

Abstract

Alternative explanations for aneuploid phenotypes are evaluated according to clinical and experimental predictions. The additive hypothesis views the diverse manifestations of aneuploidy as the simple sum of individual gene dosage effects. The interactive hypothesis views aneuploid characteristics as network properties of genes within and outside the aneuploid segment. The importance and historical context of this debate are emphasized, and the 2 hypotheses are contrasted in terms of their experimental predictions and explanatory power. In particular, the concepts of colinearity and continuity derived from single gene action are explicitly examined in human aneuploidy with the conclusion they are likely to be false assumptions.

Entities:  

Mesh:

Year:  1990        PMID: 2202218     DOI: 10.1002/ajmg.1320360426

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  A case of duplication of 13q32-->qter and deletion of 18p11.32-->pter with mild phenotype: Patau syndrome and duplications of 13q revisited.

Authors:  N Helali; A K Iafolla; S G Kahler; M B Qumsiyeh
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

Review 2.  Impact of rearrangements on function and position of chromosomes in the interphase nucleus and on human genetic disorders.

Authors:  M B Qumsiyeh
Journal:  Chromosome Res       Date:  1995-12       Impact factor: 5.239

3.  Molecular mapping of the Edwards syndrome phenotype to two noncontiguous regions on chromosome 18.

Authors:  L Boghosian-Sell; R Mewar; W Harrison; R M Shapiro; E H Zackai; J Carey; L Davis-Keppen; L Hudgins; J Overhauser
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

Review 4.  Directly transmitted unbalanced chromosome abnormalities and euchromatic variants.

Authors:  J C K Barber
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.